Skip to main content
SpringerLink
Log in

Measurement of statin exposure in the absence of information on prescribed doses

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Andrade SE, Kahler KH, Frech F, Chan KA (2006) Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15:565–574

    Article  PubMed  Google Scholar 

  2. Hess LM, Raebel MA, Conner DA, Malone DC (2006) Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 40:1280–1288

    Article  PubMed  Google Scholar 

  3. Vink NM, Klungel OH, Stolk RP, Denig P (2009) Comparison of various measures for assessing medication refill adherence using prescription data. Pharmacoepidemiol Drug Saf 18:159–165

    Article  CAS  PubMed  Google Scholar 

  4. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT (2010) The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106:86–94

    Article  CAS  PubMed  Google Scholar 

  5. Ruokoniemi P, Korhonen MJ, Helin-Salmivaara A, Lavikainen P, Jula A, Junnila SY, Kettunen R, Huupponen R (2011) Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study. Br J Clin Pharmacol 71:766–776

    Article  PubMed Central  PubMed  Google Scholar 

  6. Helin-Salmivaara A, Korhonen MJ, Lehenkari P, Junnila SY, Neuvonen PJ, Ruokoniemi P, Huupponen R (2012) Statins and hip fracture prevention—a population based cohort study in women. PLoS One 7:e48095

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Haukka J, Niskanen L, Partonen T, Lönnqvist J, Tiihonen J (2012) Statin usage and all-cause and disease-specific mortality in a nationwide study. Pharmacoepidemiol Drug Saf 21:61–69

    Article  CAS  PubMed  Google Scholar 

  8. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment, 2014. Oslo, 2013. Available at: http://www.whocc.no/atc_ddd_publications/guidelines/. Accessed 5 June 2014

  9. Dormuth CR, Schneeweiss S, Brookhart AM, Carney G, Bassett K, Adams S, Wright JM (2008) Frequency and predictors of tablet splitting in statin prescriptions: a population-based analysis. Open Med 2:e74–82

    PubMed Central  PubMed  Google Scholar 

  10. Lesen E, Sandström TZ, Carlsten A, Jönsson AK, Mårdby AC, Sundell KA (2011) A comparison of two methods for estimating refill adherence to statins in Sweden: the RARE project. Pharmacoepidemiol Drug Saf 20:1073–1079

    Article  PubMed  Google Scholar 

  11. Walley T, Folino-Gallo P, Stephens P, Van Ganse E (2005) Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997–2003. Br J Clin Pharmacol 60:543–551

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Tirkkonen T, Ryynänen A, Vahlberg T, Irjala K, Klaukka T, Huupponen R, Laine K (2008) Frequency and clinical relevance of drug interactions with lovastatin and simvastatin: an observational database study. Drug Saf 31:231–24

    Article  CAS  PubMed  Google Scholar 

  13. Ruokoniemi P, Sund R, Arffman M, Helin-Salmivaara A, Huupponen R, Keskimäki I, Vehko T, Korhonen MJ (2014) Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Finland. BMJ Open 19;4:e005402

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmacy, University of Eastern Finland, Kuopio, Finland

    Tomi Romppainen & Emma Aarnio

  2. Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, 20014, Finland

    Maria Rikala, Maarit Jaana Korhonen & Risto Huupponen

  3. Unit of Clinical Pharmacology, Turku University Hospital, Turku, Finland

    Emma Aarnio & Risto Huupponen

  4. Department of Public Health, University of Turku, Turku, Finland

    Maarit Jaana Korhonen

  5. Research Department, The Social Insurance Institution, Helsinki, Finland

    Leena K Saastamoinen

Authors
  1. Tomi Romppainen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Rikala
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emma Aarnio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maarit Jaana Korhonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Leena K Saastamoinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Risto Huupponen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Rikala.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Romppainen, T., Rikala, M., Aarnio, E. et al. Measurement of statin exposure in the absence of information on prescribed doses. Eur J Clin Pharmacol 70, 1275–1276 (2014). https://doi.org/10.1007/s00228-014-1737-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-014-1737-3

Keywords

Search

Navigation